PolyNovo Limited (CALZF)
USD 0.8
(-0.04%)
USD 0.8
(-0.04%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 4.04 Million AUD | 249.36% |
| 2023 | -2.7 Million AUD | -283.28% |
| 2022 | 2.12 Million AUD | 162.5% |
| 2021 | -3.4 Million AUD | -4.13% |
| 2020 | -3.27 Million AUD | 23.09% |
| 2019 | -4.25 Million AUD | 38.41% |
| 2018 | -6.9 Million AUD | -20.47% |
| 2017 | -5.73 Million AUD | -38.03% |
| 2016 | -4.15 Million AUD | -11.02% |
| 2015 | -3.76 Million AUD | 4.06% |
| 2014 | -3.89 Million AUD | -21.65% |
| 2013 | -3.2 Million AUD | 21.51% |
| 2012 | -4.08 Million AUD | -12.66% |
| 2011 | -3.63 Million AUD | -45.71% |
| 2010 | -2.49 Million AUD | 1.61% |
| 2009 | -2.52 Million AUD | 47.17% |
| 2008 | -4.78 Million AUD | 64.98% |
| 2007 | -13.66 Million AUD | -11.12% |
| 2006 | -12.29 Million AUD | -8.59% |
| 2005 | -11.32 Million AUD | 7.15% |
| 2004 | -12.19 Million AUD | -33.22% |
| 2003 | -9.15 Million AUD | -265.91% |
| 2002 | -2.5 Million AUD | 50.47% |
| 2001 | -5.05 Million AUD | -42.25% |
| 2000 | -3.55 Million AUD | -118.08% |
| 1999 | -1.62 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 862 Thousand AUD | -1.71% |
| 2024 FY | - AUD | 199.96% |
| 2024 Q1 | 456.5 Thousand AUD | 152.64% |
| 2024 Q4 | 862 Thousand AUD | 0.0% |
| 2024 Q2 | 877 Thousand AUD | 92.11% |
| 2023 Q1 | -1.29 Million AUD | -52.42% |
| 2023 Q4 | -867.26 Thousand AUD | -49.91% |
| 2023 Q3 | -578.53 Thousand AUD | 77.82% |
| 2023 Q2 | -2.6 Million AUD | -101.22% |
| 2023 FY | - AUD | -283.28% |
| 2022 Q2 | 2.52 Million AUD | 95.67% |
| 2022 Q3 | -330.32 Thousand AUD | -113.06% |
| 2022 Q4 | -850.3 Thousand AUD | -157.41% |
| 2022 Q1 | 1.29 Million AUD | 276.86% |
| 2022 FY | - AUD | 162.5% |
| 2021 Q2 | -1.63 Million AUD | -13.66% |
| 2021 Q3 | -315.37 Thousand AUD | 80.75% |
| 2021 FY | - AUD | -4.13% |
| 2021 Q4 | -730.75 Thousand AUD | -131.71% |
| 2021 Q1 | -1.44 Million AUD | -16.2% |
| 2020 Q4 | -1.24 Million AUD | -51.67% |
| 2020 Q1 | -957.97 Thousand AUD | 40.43% |
| 2020 Q2 | -2 Million AUD | -109.27% |
| 2020 Q3 | -817.95 Thousand AUD | 59.2% |
| 2020 FY | - AUD | 23.09% |
| 2019 FY | - AUD | 38.41% |
| 2019 Q4 | -1.6 Million AUD | -279.16% |
| 2019 Q3 | -424.14 Thousand AUD | 57.26% |
| 2019 Q2 | -992.33 Thousand AUD | 0.0% |
| 2019 Q1 | -992.33 Thousand AUD | 25.11% |
| 2018 Q4 | -1.32 Million AUD | 0.0% |
| 2018 FY | - AUD | -20.47% |
| 2018 Q3 | -1.32 Million AUD | 13.29% |
| 2018 Q2 | -1.52 Million AUD | 0.0% |
| 2018 Q1 | -1.52 Million AUD | -3.54% |
| 2017 Q3 | -1.47 Million AUD | -51.68% |
| 2017 Q2 | -973.06 Thousand AUD | 0.0% |
| 2017 Q1 | -973.06 Thousand AUD | -88.66% |
| 2017 FY | - AUD | -38.03% |
| 2017 Q4 | -1.47 Million AUD | 0.0% |
| 2016 Q3 | -515.77 Thousand AUD | 54.66% |
| 2016 FY | - AUD | -11.02% |
| 2016 Q4 | -515.77 Thousand AUD | 0.0% |
| 2016 Q2 | -1.13 Million AUD | 0.0% |
| 2016 Q1 | -1.13 Million AUD | -57.35% |
| 2015 Q3 | -722.88 Thousand AUD | -7.04% |
| 2015 Q1 | -675.34 Thousand AUD | 25.01% |
| 2015 Q2 | -675.34 Thousand AUD | -0.0% |
| 2015 FY | - AUD | 4.06% |
| 2015 Q4 | -722.88 Thousand AUD | 0.0% |
| 2014 Q3 | -900.6 Thousand AUD | -58.81% |
| 2014 Q2 | -567.09 Thousand AUD | 0.0% |
| 2014 FY | - AUD | -21.65% |
| 2014 Q1 | -567.09 Thousand AUD | -30.78% |
| 2014 Q4 | -900.6 Thousand AUD | 0.0% |
| 2013 FY | - AUD | 21.51% |
| 2013 Q2 | -325.73 Thousand AUD | -0.0% |
| 2013 Q1 | -325.73 Thousand AUD | 0.0% |
| 2013 Q4 | -433.62 Thousand AUD | 0.0% |
| 2013 Q3 | -433.62 Thousand AUD | -33.12% |
| 2012 FY | - AUD | -12.66% |
| 2011 FY | - AUD | -45.71% |
| 2010 FY | - AUD | 1.61% |
| 2009 FY | - AUD | 47.17% |
| 2008 FY | - AUD | 64.98% |
| 2007 FY | - AUD | -11.12% |
| 2006 FY | - AUD | -8.59% |
| 2005 FY | - AUD | 7.15% |
| 2004 FY | - AUD | -33.22% |
| 2003 FY | - AUD | -265.91% |
| 2002 FY | - AUD | 50.47% |
| 2001 FY | - AUD | -42.25% |
| 2000 FY | - AUD | -118.08% |
| 1999 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | -1.16 Million USD | 447.68% |
| SS Innovations International, Inc. | -20.37 Million USD | 119.862% |
| Össur hf. | 137.38 Million USD | 97.054% |
| Össur hf. | 137.38 Million USD | 97.054% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| QHSLab, Inc. | -91.29 Thousand USD | 4532.98% |
| BrainsWay Ltd. | -2.31 Million USD | 275.119% |
| BioElectronics Corporation | -274.29 Thousand USD | 1575.446% |
| AVITA Medical, Inc. | -39.56 Million USD | 110.228% |
| Zecotek Photonics Inc. | -3.44 Million USD | 217.57% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| Wellstar International, Inc. | -1.35 Million USD | 398.337% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 26.706% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 58.595% |
| Escalon Medical Corp. | -58.46 Thousand USD | 7022.564% |
| Aurora Spine Corporation | -454.37 Thousand USD | 990.668% |
| NewCardio, Inc. | -9.37 Million USD | 143.148% |
| Avitar, Inc. | -1.66 Million USD | 342.655% |
| Vivos Inc. | -2.79 Million USD | 244.89% |
| Theraclion SA | -2.05 Million USD | 297.339% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | 2147.134% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| REMSleep Holdings, Inc. | -1.66 Million USD | 342.545% |
| Positron Corporation | -1.45 Million USD | 378.69% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 1168.075% |
| Nanomix Corporation | -8.13 Million USD | 149.719% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | 672.394% |
| Stratec SE | 39.91 Million USD | 89.861% |
| Heart Tronics, Inc. | -14.85 Million USD | 127.24% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | 3522.15% |
| Electromedical Technologies, Inc. | -1.72 Million USD | 335.033% |
| Lombard Medical, Inc. | -28.06 Million USD | 114.419% |
| ALR Technologies Inc. | -6.4 Million USD | 163.231% |
| MicroPort Scientific Corporation | -347.57 Million USD | 101.164% |
| Vycor Medical, Inc. | 100.94 Thousand USD | -3909.193% |
| VMS Rehab Systems, Inc. | -68.55 USD | 5903819.912% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 130.482% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 229.463% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 144.22% |
| Ingen Technologies, Inc. | -8639.00 USD | 46945.7% |
| United American Healthcare Corporation | -59 Thousand USD | 6959.322% |
| Odyssey Group International, Inc. | -2.13 Million USD | 289.283% |
| IR-Med Inc. | -4.89 Million USD | 182.727% |
| Polarean Imaging plc | -11.19 Million USD | 136.15% |
| ECGI Holdings, Inc. | -2.99 Million USD | 235.332% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | 743.215% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | 887.316% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | -787.383% |
| Urologix, Inc. | -6.34 Million USD | 163.793% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 426.539% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | 628.352% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | 1916.281% |
| Smith & Nephew plc | 1 Billion USD | 99.596% |
| NIOX Group Plc | 11.07 Million USD | 63.459% |
| Fuse Medical, Inc. | 1.83 Million USD | -120.507% |
| Broncus Holding Corporation | -25.19 Million USD | 116.06% |
| Brain Scientific Inc. | -7.93 Million USD | 151.01% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 143.095% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | 22094.565% |